Evidence map›Paper›PMID 28650476›Full record

ArticleNature methods2017

CrY2H-seq: a massively multiplexed assay for deep-coverage interactome mapping.

Shelly A Wanamaker, Renee M Garza, Andrew MacWilliams, Joseph R Nery, Anna Bartlett, Rosa Castanon, Adeline Goubil, Joseph Feeney, Ronan O'Malley, Shao-Shan C Huang and 3 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. Possible regulation ofmicroPublication biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Arabidopsis research in 2030: Translating the computable plant.The Plant journal : for cell and molecular biology · 2025
    Review
  10. Article
  11. Review
  12. Identification ofForestry research · 2025
    Article
  13. Article
  14. Powdery mildew effectors AVRMolecular plant pathology · 2024
    Article
  15. Article
  16. Genome editing and molecular analyses of anPlant biotechnology (Tokyo, Japan) · 2023
    Article
  17. Article
  18. Article
  19. Characterization of Arbuscular Mycorrhizal Effector Proteins.International journal of molecular sciences · 2023
    Review
  20. Proximity Labeling in Plants.Annual review of plant biology · 2023
    Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Shelly A WanamakerGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Renee M GarzaGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Andrew MacWilliamsGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Joseph R NeryGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Anna BartlettGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Rosa CastanonGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Adeline GoubilGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Joseph FeeneyGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Ronan O'MalleyGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Shao-Shan C HuangGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Zhuzhu Z ZhangGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Mary GalliGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Joseph R EckerGenomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
Salk Institute for Biological Studies · USInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUniversity of California, San Diego · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Broad-scale protein-protein interaction mapping is a major challenge given the cost, time, and sensitivity constraints of existing technologies. Here, we present a massively multiplexed yeast two-hybrid method, CrY2H-seq, which uses a Cre recombinase interaction reporter to intracellularly fuse the coding sequences of two interacting proteins and next-generation DNA sequencing to identify these interactions en masse. We applied CrY2H-seq to investigate sparsely annotated Arabidopsis thaliana transcription factors interactions. By performing ten independent screens testing a total of 36 million binary interaction combinations, and uncovering a network of 8,577 interactions among 1,453 transcription factors, we demonstrate CrY2H-seq's improved screening capacity, efficiency, and sensitivity over those of existing technologies. The deep-coverage network resource we call AtTFIN-1 recapitulates one-third of previously reported interactions derived from diverse methods, expands the number of known plant transcription factor interactions by three-fold, and reveals previously unknown family-specific interaction module associations with plant reproductive development, root architecture, and circadian coordination.

Indexed as

Two-Hybrid System TechniquesArabidopsisHigh-Throughput Nucleotide SequencingProtein Interaction MappingProteomeSequence Analysis, DNATranscription FactorsProteomeTranscription Factors

Identifiers

PMID28650476
PMCPMC5564216
OpenAlexW2656283085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.